BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khan A, Mushtaq M, Movva G, Sohal A, Yang J. Gastrointestinal disease in end-stage renal disease. World J Nephrol 2025; 14(1): 101917 [PMID: 40134640 DOI: 10.5527/wjn.v14.i1.101917]
URL: https://www.wjgnet.com/1948-5190/full/v14/i1/101917.htm
Number Citing Articles
1
Mete Ucdal, Evren Ekingen. Comparative Evaluation of A4C, CHAMPS, and CAGIB Scores for Risk Stratification in Hemodialysis Patients with Acute Gastrointestinal BleedingDiagnostics 2026; 16(3) doi: 10.3390/diagnostics16030401
2
Lykke Ida Kaas Oldenburg, Sine Pfeiffer Haugaard, Tobias Karlsson, Victoria Kegel‐Hübner, Mahera Parwez, Christoffer Wiingaard, Anne Flint. Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of ZenagamtideDiabetes, Obesity and Metabolism 2026;  doi: 10.1111/dom.71096
3
Jianfang Chen, Yi Zong. Advances in evidence-based nursing for preventing adverse reactions to radiocontrast agents in patients undergoing gastrointestinal surgeryJournal of Radiation Research and Applied Sciences 2026; 19(2) doi: 10.1016/j.jrras.2026.102331
4
Maiko Abumiya, Ko Abe, Atsushi Watanabe, Naoto Takahashi. Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysisCancer Chemotherapy and Pharmacology 2026; 96(1) doi: 10.1007/s00280-026-04919-4
5
Rami Dwairi, Khitam Al-Refu, Basil Aldiabat, Heba Al-Smirat, Nidal Awad Alnawaiseh, Waleed Alhalabi, Yousef M. Al-Saraireh. Modality of Dialysis and Gastrointestinal Symptoms: A Cross-Sectional Study in Jordanian AdultsKidney and Dialysis 2025; 6(1) doi: 10.3390/kidneydial6010001
6
Jiaoyan Li, Jie Liang, Xiaoshuang Shi, Wenjie Lu. Difference in the risk of gastrointestinal manifestations between peritoneal and hemodialysis patients: a systematic review and meta-analysisPeerJ 2026; 14 doi: 10.7717/peerj.21090